Health Care & Life Sciences » Pharmaceuticals | Boston Therapeutics Inc.

Boston Therapeutics Inc.

Boston Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$2.27 M
Shares Outstanding
111.13 M
Public Float
61.2 M

Profile

Address
354 Merrimack Street No. 4
Lawrence Massachusetts 01843
United States
Employees -
Website http://www.bostonti.com
Updated 07/08/2019
Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN.

Financials

View All

Carl W. Rausch
CEO, CFO, Director & Principal Accounting Officer
Chi-Heng Cheng
Director